Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • HealthTech Dialogues
    • US Healthtech Startup...

    US Healthtech Startup AkosMD Coming to India

    Written by supriya kashyap kashyap Published On 2017-04-17T11:48:12+05:30  |  Updated On 17 April 2017 11:48 AM IST
    US Healthtech Startup AkosMD Coming to India

    AkosMD was started in the US to facilitate affordable and faster primary healthcare, a basic right which often is too expensive and takes long to access. To reduce costs and waiting time, the AkosMD app user could connect to doctors, have a conversation, receive a prognosis and prescription, and even arrange follow up schedules and referrals.


    The founders of AkosMD are now planning to bring the same venture to India to provide affordable primary healthcare access to the millions of Indians who can’t afford a doctor or lives to far from a medical professional. The Indian version of the service will be called Instaa MED. The venture has the backing of Dr.Bindeshwar Pathak, social reformer and founder of Sulabh International, a pivotal figure of the Clean India movement.


    AkosMD is a venture managed by US based Dr. Kishlay Anand and Dr. Swaraj Singh. Other successful ventures that they run in India and USA are NRI Family Health, a service that takes care of elderly patients of NRIs. Another venture is imedicalconsult which provides second opinions for critically ill patients rom specialists around the world. The venture ‘kare@home’ is available to people looking at services of care givers and nurses at home.


    Chandan Kumar who manages the India business operations for the soon to be launched app said, “Being a bi-national company in the USA, this will be a good value proposition for corporate employees travelling between the US and India.”


    Long back India stopped being a provider of affordable care at the primary level or OPD. According to the AkosMD team, cost of visiting a doctor ranges from 600 to 1200 rupees depending on the specialist. Most of the time people do not know which doctor to visit and end up paying twice the amount for the same problem. AkosMD is aiming to make this primary level of consultation available as and when a patient needs it. “The app gives you reasons to not postpone addressing your health concerns for a later date for lack of time. The app makes it is easier and cheaper. You don’t have to disrupt your work schedule to seek medical help either,” said Dr Spurdha Sood, a core team member of AkosMD’s India operations.


    Dr. Kishlay, founder of the AkosMD said, “Primary care or OPD as we know is time consuming and expensive in India. Appointments may not be available when needed and if booked, getting to the hospital, parking and waiting in queues can be a challenge. In order to make the experience of consulting a doctor trustable, economical and time saving, AkosMD is introducing this app that will allow patients to in-cognito seek expert advice from doctors about health concerns they face right from their smartphones. Services are not limited to OPD care but patients are assisted with all their needs post consultation. We hope to launch the app in July 2017.”

    AkosMDAkosMD appDr Kishlay AnandDr Swaraj SinghHealthcareSulabh International
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok